Evidence map›Paper›PMID 35103888›Full record

ArticleAIDS and behavior2022

Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda.

Karl C Alcover, Nneka I Emenyonu, Robin Fatch, Allen Kekibiina, Kara Marson, Gabriel Chamie, Winnie R Muyindike, Brian Beesiga, Moses R Kamya, Sara Lodi and 3 more

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Karl C AlcoverDepartment of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD, 20814, USA. karl.alcover@usuhs.edu.ORCID http://orcid.org/0000-0002-3567-7746
Nneka I EmenyonuDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Robin FatchDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Allen KekibiinaMbarara University of Science and Technology, Mbarara, Uganda.
Kara MarsonDivision of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
Gabriel ChamieDivision of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
Winnie R MuyindikeDepartment of Internal Medicine, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Brian BeesigaInfectious Diseases Research Collaboration, Kampala, Uganda.
Moses R KamyaDepartment of Medicine, Makerere University, Kampala, Uganda.
Sara LodiDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Jeremy C KaneDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
Judith A HahnDepartments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Michael G McDonellBehavioral Health Innovations, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.
University of California, San Francisco · USMbarara University of Science and Technology · UGBoston University · USColumbia University · USInfectious Diseases Research Collaboration · UGMakerere University · UGUniformed Services University of the Health Sciences · USWashington State University Spokane · US

Funding

Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)U01AA026223 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2017 to 2021
$2.8M
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 2/2)U01AA026221 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAMIE, GABRIEL · 2017 to 2021
$2.7M
Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkersK01AA026523 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KANE, JEREMY CALVIN · 2020 to 2024
$881k
NIAAA NIH HHS K01 AA026523NIAAA NIH HHS K24 AA022586NIAAA NIH HHS U01 AA026221NIAAA NIH HHS U01 AA026223
6 · The paper itself

Abstract

Screening and assessing alcohol use accurately to maximize positive treatment outcomes remain problematic in regions with high rates of alcohol use and HIV and TB infections. In this study, we examined the concordance between self-reported measures of alcohol use and point-of-care (POC) urine ethyl glucuronide (uEtG) test results among persons with HIV (PWH) in Uganda who reported drinking in the prior 3 months. For analyses, we used the screening data of a trial designed to examine the use of incentives to reduce alcohol consumption and increase medication adherence to examine the concordance between POC uEtG (300 ng/mL cutoff) and six measures of self-reported alcohol use. Of the 2136 participants who completed the alcohol screening, 1080 (50.6%) tested positive in the POC uEtG test, and 1756 (82.2%) self-reported using alcohol during the prior 72 h. Seventy-two percent of those who reported drinking during the prior 24 h had a uEtG positive test, with lower proportions testing uEtG positive when drinking occurred 24-48 h (64.7%) or 48-72 h (28.6%) prior to sample collection. In multivariate models, recency of drinking, number of drinks at last alcohol use, and Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) score were associated with uEtG positivity. The highest area under the curve (AUC) for a uEtG positive test was for recency of drinking. Overall, we concluded that several measures of drinking were associated with POC uEtG positivity, with recency of drinking, particularly drinking within the past 24 h, being the strongest predictor of uEtG positivity.

Indexed as

AlcoholismHIV InfectionsAlcohol DrinkingGlucuronatesHumansPoint-of-Care SystemsSelf ReportUgandaethyl glucuronideGlucuronatesAfricaAlcoholHIVLatent TB infectionTuberculosis (TB)

Identifiers

PMID35103888
PMCPMC9256760
OpenAlexW4210658432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.